Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-303156
Filing Date
2021-10-20
Accepted
2021-10-20 17:13:30
Documents
4
Effectiveness Date
2021-10-20

Document Format Files

Seq Description Document Type Size
1 S-8 d152143ds8.htm S-8 58163
2 EX-5.1 d152143dex51.htm EX-5.1 9696
3 EX-23.1 d152143dex231.htm EX-23.1 2184
4 GRAPHIC g152143dsp10.jpg GRAPHIC 6951
  Complete submission text file 0001193125-21-303156.txt   80870
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 472566423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-260385 | Film No.: 211334866
SIC: 2834 Pharmaceutical Preparations